Thyrocare Technologies Bonus Issue: Today Is the Last Day to Buy Shares Ahead of 2:1 Bonus

Mumbai, November 27: Investors looking to receive Thyrocare Technologies’ 2:1 bonus shares must buy the stock today, as the shares will trade ex-bonus tomorrow, November 28.

The ex-bonus date is the cut-off for eligibility; investors must hold the shares before this date to be included in the company’s shareholders’ list. Thyrocare Technologies has also set the record date as November 28, which will be used to finalise the list of shareholders eligible for the bonus issue.

Thyrocare Technologies Ltd (NSE: THYROCARE, BSE: 539871) is a leading Indian multinational chain of diagnostic and preventive care laboratories. It operates one of the largest and most automated Central Processing Laboratories (CPLs) in India, complemented by a wide network of Regional Processing Laboratories (RPLs) and collection centres across the country and in select international markets. The company was established in 1996 and is headquartered in Mumbai, Maharashtra.

Thyrocare Technologies Bonus Issue Details

Thyrocare Technologies has announced a bonus issue of 2:1. This means that shareholders holding 1 share of the company as on the record date will be eligible to receive 2 additional shares, taking the total number of shares to 3.

However, investors should note that Thyrocare Technologies’ share price is expected to drop by one-third tomorrow, reflecting the 2:1 bonus issue. This adjustment ensures that, with the addition of two bonus shares for every share held, the total investment value for shareholders remains unchanged.

There is no cause for concern, as this price adjustment is purely procedural and does not affect the market capitalisation of the company or the overall value of an investor’s holdings.

Shares Fall by 0.68% at ₹1,485.50

As of 11:05 AM, Thyrocare Technologies’ share price was down by 0.68%, or 10.20 points, and was trading at ₹1,485.50. Until now, the shares have traded within a range of ₹1,506.80 and ₹1,482.90. The traded volume stood at 81.88 thousand shares, with the company’s market cap at ₹7,935 crore. The shares have their 52-week high at ₹1,610 and their 52-week low at ₹658.

Investor Takeaway

Thyrocare Technologies’ shares will trade ex-bonus tomorrow and will fall by a factor of 3. The company’s bonus issue will increase liquidity for the shares, and will attract more investors due to the reduced share price. However, only eligible shareholders will receive the bonus shares. Hence, investors must hold or buy the shares of the company by the end of today’s trading session. Although the share price is marginally down, it may see higher demand as investors rush to buy the shares before the ex-bonus and record date tomorrow.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations